# Use of Cell Therapy to Enhance Arthroscopic Knee Cartilage Surgery

> **NCT01799876** · NA · COMPLETED · sponsor: **Fondren Orthopedic Group L.L.P.** · enrollment: 48 (actual)

## Conditions studied

- Articular Cartilage Defect Grade III or IV of the Knee

## Interventions

- **PROCEDURE:** Autologous Cell
- **PROCEDURE:** Standard microfracture arthroscopic surgery

## Key facts

- **NCT ID:** NCT01799876
- **Lead sponsor:** Fondren Orthopedic Group L.L.P.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2016-08
- **Final completion:** 2017-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01799876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01799876, "Use of Cell Therapy to Enhance Arthroscopic Knee Cartilage Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01799876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*